138 related articles for article (PubMed ID: 25181428)
1. Concentrations of eNOS, VEGF, ACE and PlGF in maternal blood as predictors of impaired fetal growth in pregnancy complicated by gestational hypertension/preeclampsia.
Wender-Ozegowska E; Zawiejska A; Iciek R; Brązert J
Hypertens Pregnancy; 2015 Feb; 34(1):17-23. PubMed ID: 25181428
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of endothelial nitric oxide synthase, angiotensin-converting enzyme, vascular endothelial growth factor and placental growth factor in maternal blood and maternal metabolic status in pregnancy complicated by hypertensive disorders.
Zawiejska A; Wender-Ozegowska E; Iciek R; Brazert J
J Hum Hypertens; 2014 Nov; 28(11):670-6. PubMed ID: 25186136
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
4. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
5. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum placental growth factor and fetal SGA in pregnancy complicated by type 1 diabetes mellitus.
Gutaj P; Wender-Ożegowska E; Iciek R; Zawiejska A; Pietryga M; Brązert J
J Perinat Med; 2014 Sep; 42(5):629-33. PubMed ID: 24519713
[TBL] [Abstract][Full Text] [Related]
7. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
Bersinger NA; Ødegård RA
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
[TBL] [Abstract][Full Text] [Related]
9. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
10. The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2015 Jan; 28(1):26-32. PubMed ID: 24588201
[TBL] [Abstract][Full Text] [Related]
11. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
13. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks' gestation in normal and pathological pregnancies.
Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
Fetal Diagn Ther; 2014; 36(2):106-16. PubMed ID: 24457972
[TBL] [Abstract][Full Text] [Related]
15. Use of placental growth factor and uterine artery doppler pulsatility index in pregnancies involving intrauterine fetal growth restriction or preeclampsia to predict perinatal outcomes.
Gomez-Roig MD; Mazarico E; Sabria J; Parra J; Oton L; Vela A
Gynecol Obstet Invest; 2015; 80(2):99-105. PubMed ID: 25924544
[TBL] [Abstract][Full Text] [Related]
16. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks.
Poon LC; Lesmes C; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):437-45. PubMed ID: 25988293
[TBL] [Abstract][Full Text] [Related]
17. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
[TBL] [Abstract][Full Text] [Related]
18. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia.
Krauss T; Pauer HU; Augustin HG
Hypertens Pregnancy; 2004; 23(1):101-11. PubMed ID: 15117604
[TBL] [Abstract][Full Text] [Related]
19. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
20. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
